» Articles » PMID: 35277049

Hydrolyzed Proteins and Vegetable Peptides: Anti-Inflammatory Mechanisms in Obesity and Potential Therapeutic Targets

Overview
Journal Nutrients
Date 2022 Mar 12
PMID 35277049
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic low-grade inflammation is present in overweight and obesity, causing changes in several metabolic pathways. It impairs systemic functioning and positively feeds back the accumulation of more adipose tissue. Studies with hydrolyzed proteins and plant peptides have demonstrated a potential anti-inflammatory and immunomodulatory effect of these peptides. However, it is challenging and necessary to explore the mechanism of action of such molecules because understanding their effects depends on their structural characterizations. Furthermore, the structure might also give insights into safety, efficacy and efficiency, with a view of a possible health application. Thus, the present narrative review aimed to discuss the mechanisms of action of hydrolyzed proteins and plant peptides as anti-inflammatory agents in obesity. Keywords and related terms were inserted into databases for the search. Based on the studies evaluated, these biomolecules act by different pathways, favoring the reduction of inflammatory cytokines and adipokines and the polarization of macrophages to the M2 phenotype. Finally, as a future perspective, bioinformatics is suggested as a tool to help understand and better use these molecules considering their applicability in pre-clinical and clinical studies.

Citing Articles

Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.

Jiao Q, Huang Y, He J, Xu Y Pharmaceutics. 2025; 17(2).

PMID: 40006605 PMC: 11859201. DOI: 10.3390/pharmaceutics17020238.


Characteristics of soybean () protein hydrolysate by bromelain and its effect on inflammation and kidney disorders in gentamicin-induced male Wistar rats.

Hidayat M, Barnas A, Nussy V, Wantania T, Prahastuti S, Sriwidodo S Iran J Basic Med Sci. 2025; 28(1):56-62.

PMID: 39877638 PMC: 11771338. DOI: 10.22038/ijbms.2024.78131.16885.


Sacha Inchi ( L.) Protein Hydrolysate as a New Ingredient of Functional Foods.

Lemus-Conejo A, Villanueva-Lazo A, Martin M, Millan F, Millan-Linares M Foods. 2024; 13(13).

PMID: 38998552 PMC: 11241537. DOI: 10.3390/foods13132045.


Identifying lifestyle factors associated to co-morbidity of obesity and psychiatric disorders, a pilot study.

Gaskell C, Sarada P, Aleem E, Bendriss G Front Public Health. 2023; 11:1132994.

PMID: 37206863 PMC: 10188954. DOI: 10.3389/fpubh.2023.1132994.


Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases.

Lee V, Janisse S, Heffern M Chem Soc Rev. 2023; 52(11):3927-3945.

PMID: 37203389 PMC: 10281457. DOI: 10.1039/d3cs00167a.


References
1.
Nasri H, Baradaran A, Shirzad H, Rafieian-Kopaei M . New concepts in nutraceuticals as alternative for pharmaceuticals. Int J Prev Med. 2015; 5(12):1487-99. PMC: 4336979. View

2.
Yi G, Li H, Liu M, Ying Z, Zhang J, Liu X . Soybean protein-derived peptides inhibit inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPK-JNK and NF-kappa B activation. J Food Biochem. 2020; 44(8):e13289. DOI: 10.1111/jfbc.13289. View

3.
Wang L, Sun P, Wu Y, Wang L . Metabolic tissue-resident CD8 T cells: A key player in obesity-related diseases. Obes Rev. 2020; 22(3):e13133. DOI: 10.1111/obr.13133. View

4.
Zhu W, Ren L, Zhang L, Qiao Q, Farooq M, Xu Q . The Potential of Food Protein-Derived Bioactive Peptides against Chronic Intestinal Inflammation. Mediators Inflamm. 2020; 2020:6817156. PMC: 7499337. DOI: 10.1155/2020/6817156. View

5.
Muller R . JAK inhibitors in 2019, synthetic review in 10 points. Eur J Intern Med. 2019; 66:9-17. DOI: 10.1016/j.ejim.2019.05.022. View